<DOC>
	<DOC>NCT00156078</DOC>
	<brief_summary>A study of pregabalin efficacy and safety in a racially and culturally diverse group of subjects with painful diabetic peripheral neuropathy (DPN).</brief_summary>
	<brief_title>A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN)</brief_title>
	<detailed_description />
	<mesh_term>Pain</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Diagnosis of Type 1 or 2 diabetes mellitus. Diagnosis of painful DPN for at least 12 months but less than 5 years in duration. Neurologic Disorders unrelated to diabetic neuropathy that may confuse or confound the assessment of neuropathic pain. Presence of any severe pain associated with conditions other than DPN that may confuse or confound the assessment of neuropathic pain.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>